{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001635077","name":"Aclarion, Inc.","summary":"Aclarion, Inc. is a healthcare technology company that uses Magnetic Resonance Spectroscopy (MRS) and proprietary biomarkers to help clinicians identify pain-generating intervertebral discs in the spine. Its primary commercial product, NOCISCAN, is a software platform that post-processes MRS exam data to assist surgeons in surgical decision-making for chronic discogenic low back pain. The company also leverages AI for quality control and plans to expand into conservative therapies, neck pain, and other clinical applications.","people":[],"products":[{"name":"NOCISCAN","type":"software","description":"Proprietary software platform using MRS data and biomarker algorithms to identify pain-generating intervertebral discs, supporting surgical and treatment decision-making for chronic discogenic low back pain."}],"partnerships":[{"partner_name":"Regents of the University of California, San Francisco (UCSF)","partnership_type":"licensing","description":"Exclusive license for biomarkers correlated to disc pain and structural degradation used in NOCISCAN platform.","start_date":null},{"partner_name":"Siemens","partnership_type":"OEM","description":"NOCISCAN is compatible with certain Siemens MR scanner models; estimated 1,500 compatible units in the U.S. and 4,320 worldwide.","start_date":null},{"partner_name":"Philips","partnership_type":"development","description":"First customer engagement using Philips MRS capabilities with NOCISCAN platform initiated in Q1 2025.","start_date":null},{"partner_name":"NIH Back Pain Consortium (BACPAC)","partnership_type":"strategic","description":"Aclarion technology selected to participate in NIH's $150 million BACPAC Research Program for chronic low back pain therapies.","start_date":null},{"partner_name":"NIH Biomarkers for the Evaluation of Spinal Treatments (BEST)","partnership_type":"strategic","description":"NIH selected Aclarion technology for inclusion in the prospective randomized BEST study evaluating chronic LBP treatment subgroups.","start_date":null}],"affiliations":[],"origin":{"leaf":"a7eff4b99f84826887a90c3bdc39a9c8e145217de6167568109201bb8523ba76","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"bc562dd55d9efd3d87db256b85574091ab8b86de0a70509157ee81afc91ee228","parent":"1160d7577e1ecab5d0e56fa3a428c1f5706f96da82ffde806a57b2f05e1087d9","source":"0001683168-26-001986","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":418,"hourly_limit":500,"remaining":82,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}